152 related articles for article (PubMed ID: 11882029)
1. Trypanosoma cruzi mitochondrial malate dehydrogenase triggers polyclonal B-cell activation.
Montes CL; Zuñiga EI; Vazquez J; Arce C; Gruppi A
Clin Exp Immunol; 2002 Jan; 127(1):27-36. PubMed ID: 11882029
[TBL] [Abstract][Full Text] [Related]
2. A Trypanosoma cruzi alkaline antigen induces polyclonal B-cell activation of normal murine spleen cells by T-cell-independent, BCR-directed stimulation.
Montes CL; Zuñiga E; Minoprio P; Vottero-Cima E; Gruppi A
Scand J Immunol; 1999 Aug; 50(2):159-66. PubMed ID: 10447920
[TBL] [Abstract][Full Text] [Related]
3. A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies.
Hernández-Munaín C; De Diego JL; Alcina A; Fresno M
J Exp Med; 1992 Jun; 175(6):1473-82. PubMed ID: 1375261
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi cytosolic alkaline antigens (FI) induce polyclonal activation in murine normal B cells.
Montes CL; Vottero-Cima E; Gruppi A
Scand J Immunol; 1996 Aug; 44(2):93-100. PubMed ID: 8711435
[TBL] [Abstract][Full Text] [Related]
5. A Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells.
Montes CL; Acosta-Rodríguez EV; Mucci J; Zuniga EI; Campetella O; Gruppi A
Eur J Immunol; 2006 Jun; 36(6):1474-85. PubMed ID: 16688679
[TBL] [Abstract][Full Text] [Related]
6. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.
Bryan MA; Guyach SE; Norris KA
PLoS Negl Trop Dis; 2010 Jul; 4(7):e733. PubMed ID: 20625554
[TBL] [Abstract][Full Text] [Related]
7. A 24,000 MW Trypanosoma cruzi antigen is a B-cell activator.
Da Silva AC; Espinoza AG; Taibi A; Ouaissi A; Minoprio P
Immunology; 1998 Jun; 94(2):189-96. PubMed ID: 9741340
[TBL] [Abstract][Full Text] [Related]
8. Genetic immunization converts the trypanosoma cruzi B-Cell mitogen proline racemase to an effective immunogen.
Bryan MA; Norris KA
Infect Immun; 2010 Feb; 78(2):810-22. PubMed ID: 19917711
[TBL] [Abstract][Full Text] [Related]
9. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
[TBL] [Abstract][Full Text] [Related]
10. Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies.
Minoprio P; Eisen H; Joskowicz M; Pereira P; Coutinho A
J Immunol; 1987 Jul; 139(2):545-50. PubMed ID: 2955044
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton's tyrosine kinase.
Gao W; Pereira MA
Eur J Immunol; 2001 May; 31(5):1503-12. PubMed ID: 11465107
[TBL] [Abstract][Full Text] [Related]
13. A lytic monoclonal antibody to Trypanosoma cruzi bloodstream trypomastigotes which recognizes an epitope expressed in tissues affected in Chagas' disease.
Zwirner NW; Malchiodi EL; Chiaramonte MG; Fossati CA
Infect Immun; 1994 Jun; 62(6):2483-9. PubMed ID: 7514576
[TBL] [Abstract][Full Text] [Related]
14. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
Wizel B; Nunes M; Tarleton RL
J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
[TBL] [Abstract][Full Text] [Related]
15. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
[TBL] [Abstract][Full Text] [Related]
16. Activation of Human CD11b
Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO
Front Immunol; 2018; 9():3015. PubMed ID: 30662439
[TBL] [Abstract][Full Text] [Related]
17. Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation.
Sullivan NL; Eickhoff CS; Zhang X; Giddings OK; Lane TE; Hoft DF
J Immunol; 2011 Aug; 187(3):1358-68. PubMed ID: 21715689
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.
Sullivan NL; Eickhoff CS; Sagartz J; Hoft DF
J Immunol; 2015 Feb; 194(4):1806-18. PubMed ID: 25595788
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies.
Bermejo DA; Amezcua Vesely MC; Khan M; Acosta Rodríguez EV; Montes CL; Merino MC; Toellner KM; Mohr E; Taylor D; Cunningham AF; Gruppi A
Immunology; 2011 Jan; 132(1):123-33. PubMed ID: 20875075
[TBL] [Abstract][Full Text] [Related]
20. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
Braun M; de Titto E
Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
